Zolmitriptan and Dry skin - a phase IV clinical study of FDA data

Summary:

Dry skin is reported as a side effect among people who take Zolmitriptan (zolmitriptan), especially for people who are female, 40-49 old, also take Pantoprazole, and have Muscle spasms.

The phase IV clinical study analyzes which people have Dry skin when taking Zolmitriptan. It is created by eHealthMe based on reports of 2,530 people who have side effects when taking Zolmitriptan from the FDA, and is updated regularly.

What is Zolmitriptan?

Zolmitriptan has active ingredients of zolmitriptan. It is often used in migraine. eHealthMe is studying from 2,568 Zolmitriptan users. Check the latest studies of Zolmitriptan.

What is Dry skin?

Dry skin is found to be associated with 1,974 drugs and 2,356 conditions by eHealthMe. Check the latest studies of Dry skin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 27, 2026

2,530 people reported to have side effects when taking Zolmitriptan.
Among them, 35 people (1.38%) have Dry skin.

Among these 35 people:

What is the gender of people who have Dry skin when taking Zolmitriptan? *

female: 97.06 %
male: 2.94 %

What is the age of people who have Dry skin when taking Zolmitriptan? *

What are other drugs people take besides Zolmitriptan? *

What are other side effects people have besides Dry skin? *

Headache (pain in head): 30 people, 85.71%
Itching: 30 people, 85.71%
Fatigue (feeling of tiredness): 29 people, 82.86%
Rhinorrhea (watery mucus discharge from the nose): 27 people, 77.14%
Malaise (a feeling of general discomfort or uneasiness): 25 people, 71.43%
Rashes (redness): 22 people, 62.86%
Hair Loss: 20 people, 57.14%
Monocyte Count Abnormal: 19 people, 54.29%
Lymphocyte Count Abnormal: 19 people, 54.29%
Urticaria Chronic (long lasting rash of round, red welts on the skin that itch intensely): 19 people, 54.29%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 8 people, 22.86%
Muscle Spasms (muscle contraction): 8 people, 22.86%
Menopause (end of monthly cycles in women): 7 people, 20.00%
Itching: 7 people, 20.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.71%
Immunodeficiency Common Variable: 2 people, 5.71%
Atrioventricular Block (heart block): 1 person, 2.86%
Depression: 1 person, 2.86%
Cardiac Disorder: 1 person, 2.86%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Zolmitriptan and have Dry skin?

- Check whether Dry skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zolmitriptan:

Zolmitriptan (2,568 reports)

Dry skin treatments and more:

Dry skin (131,311 reports)

Browse all side effects of Zolmitriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dry skin:

Dry skin (1,974 drugs)

Browse all the conditions that are associated with Dry skin:

Dry skin (2,356 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zolmitriptan (the active ingredients of Zolmitriptan) and Zolmitriptan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.